TC BIOPHARM (HOLDINGS) PLC

Maxim 1, 2 Parklands Way

Holytown, Motherwell ML1 4WR

Scotland, United Kingdom

 

November 2, 2023

 

VIA EDGAR

 

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jimmy McNamara

 

  Re: TC BioPharm (Holdings) plc
    Registration Statement on Form F-3/A
    File No. 333-274778

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), TC BioPharm (Holdings) plc (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Time, on Monday, November 6, 2023, or as soon thereafter as possible.

 

Please notify Stephen Cohen of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 653-8166 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

 

  Very truly yours,
   
  TC BIOPHARM (HOLDINGS) PLC
   
  By: /s/ Bryan Kobel
  Name:  Bryan Kobel
  Title: Chief Executive Officer